Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

2 Large Cap Biotech Stocks Up More Than 25% in the Last Month

Published 06/14/2021, 04:18 PM
Updated 06/14/2021, 05:30 PM
© Reuters.  2 Large Cap Biotech Stocks Up More Than 25% in the Last Month

Biogen (NASDAQ:BIIB) is up by more than 40%, following the successful approval of its Alzheimer's Treatment. BioNtech SE (BNTX) is up by more than 20% on its vaccine's approval. Find out what's next for these stocks.Biotech stocks are an area of the market that can deliver massive returns to investors, however, this potential reward does come with massive risk. &nbsp For example, Biogen (BIIB) has increased in value by more than 45% in a single month’s time. BioNtech SE (BNTX) was also up more than 25% in a month until tumbling this past Monday, June 14. &nbsp

Where do these large-cap biotech stocks go from here? Is the rapid upward run justified? Let’s take a closer look at BIIB and BNTX to get a better sense of why they have climbed so high so quickly and what could be next.

&nbsp

Continue reading on StockNews

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.